Lu Tang
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 3
- Genetics top 5%
- Glioma Diagnosis and Treatment 2
-
- Ferroptosis and cancer prognosis 6
-
- RNA modifications and cancer 7
- Circular RNAs in diseases 3
-
- Cancer Immunotherapy and Biomarkers 2
-
- Autophagy in Disease and Therapy 2
- Journals
- Analytical Chemistry (1 paper)Frontiers in Immunology (1 paper)European Journal of Pharmacology (1 paper)
- Partner nations
- China
In The Last Decade
Lu Tang
20 papers receiving 892 citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Cancer Research 348
- Genetics 225
- Pulmonary and Respiratory Medicine 295
- Immunology 180
- Molecular Biology 501
Countries citing papers authored by Lu Tang
This map shows the geographic impact of Lu Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Tang more than expected).
Fields of papers citing papers by Lu Tang
This network shows the impact of papers produced by Lu Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Tang. The network helps show where Lu Tang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lu Tang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 46 | |
| 4 | 2023 | 17 | |
| 5 | 2023 | 17 | |
| 6 | 2022 | 15 | |
| 7 | 2021 | 7 | |
| 8 | 2021 | 24 | |
| 9 | 2021 | 27 | |
| 10 | 2021 | 33 | |
| 11 | 2021 | 19 | |
| 12 | 2021 | 13 | |
| 13 | 2020 | 35 | |
| 14 | 2020 | 13 | |
| 15 | 2020 | 59 | |
| 16 | Immunotherapy for glioma: Current management and future applicationbreakdown → | 2020 | 501 |
| 17 | 2020 | 21 | |
| 18 | 2020 | 12 | |
| 19 | 2020 | 15 | |
| 20 | 2019 | 25 |
About Lu Tang
Lu Tang is a scholar working on Cancer Research, Health Informatics and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 902 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (7 papers), Ferroptosis and cancer prognosis (6 papers), MicroRNA in disease regulation (3 papers), Circular RNAs in diseases (3 papers), Glioma Diagnosis and Treatment (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Autophagy in Disease and Therapy (2 papers). The work is most often cited by research in Cancer Research (348 citations), Genetics (225 citations) and Pulmonary and Respiratory Medicine (295 citations). Lu Tang has collaborated with scholars based in China. Frequent co-authors include Shengchao Xu, Zhixiong Liu, Xizhe Li, Fan Fan, Chengke Luo, Quan Cheng, Gan Dai, Yuqiao Chen, Wei Zhuang and Hong Jiang. Their work appears in journals such as Analytical Chemistry, Frontiers in Immunology and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.